CLDX
NASDAQ HealthcareCelldex Therapeutics, Inc. - Common Stock
Biotechnology
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. It develops clinical programs, including Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. Celldex Therapeutics, Inc. is headquartered in Hampton, New Jersey.
�� 市场数据
| 价格 | $34.55 |
|---|---|
| 成交量 | 1,318,101 |
| 市值 | 2.71B |
| 贝塔系数 | 1.200 |
| RSI（14日） | 71.2 超买 |
| 200日均线 | $26.01 |
| 50日均线 | $29.17 |
| 52周最高 | $35.28 |
| 52周最低 | $17.85 |
| Forward P/E | -7.26 |
| Price / Book | 4.36 |
🎯 投资策略评分
CLDX 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🚀 Moon Shot (63/100) — 此策略 高增长潜力（高贝塔 + 超卖）.
评分最低的策略： 💰 Dividend Daddy (21/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 CLDX in your text
粘贴任何文章、记录或帖子 — 工具将提取 CLDX 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-04-17.